The Social Network THESN
Résultats de Recherche
Voir tous les résulats
  • Nous rejoindre
    Identifiant S’inscrire
    Day Mode

Rechercher

Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis

  • FAVORIS
  • Fil d’actualités
  • EXPLORE
  • Pages
  • Groupes
  • Evénements
  • Blogs
  • Financement
  • Forums
  • Articles
  • Articles
  • Utilisateurs
  • Pages
  • Groupes
  • Evénements
  • SUHAS KANDE added new article
    2025-08-28 09:21:42 -
    Calcineurin Inhibitors Market Overview, Growth Analysis, Trends and Forecast By 2032
    "Comprehensive Outlook on Executive Summary Calcineurin Inhibitors Market Size and Share Global calcineurin inhibitors market size was valued at USD 7.74 billion in 2024 and is projected to reach USD 17.36 billion by 2032, with a CAGR of 10.7% during the forecast period of 2025 to 2032. Taking up Calcineurin Inhibitors Market research report is always beneficial for businesses when it is...
    0 Commentaires 0 parts
    Please log in to like, share and comment!
  • David Cracc added new article
    2025-06-03 09:54:40 -
    Chronic Spontaneous Urticaria Clinical and Nonclinical Studies, Key Companies, Treatment Evaluation, Emerging Therapies, Treatment Algorithms, Pipeline Analysis | United BioPharma, Teva Pharmaceuticals Development, Inc., Amgen, Novartis Pharmaceuticals
        Pipeline insights for chronic spontaneous urticaria, DelveInsight According to DelveInsight analysis, the chronic spontaneous urticaria (CSU) pipeline consists of more than 20 leading companies actively developing more than 20 treatments for CSU. Overview of Chronic Spontaneous Urticaria: Urticaria, commonly known as hives, wheals, or nettle rash, is characterized by itchy, red,...
    0 Commentaires 0 parts
    Please log in to like, share and comment!
  • SUHAS KANDE added new article
    2025-09-03 12:04:29 -
    Europe Calcineurin Inhibitors Market Overview, Growth Analysis, Trends and Forecast By 2032
    "Executive Summary: Europe Calcineurin Inhibitors Market Size and Share by Application & Industry Europe calcineurin inhibitors market size was valued at USD 2.09 billion in 2024 and is projected to reach USD 4.47 billion by 2032, with a CAGR of 10.0% during the forecast period of 2025 to 2032. In the leading Europe Calcineurin Inhibitors Market report, industry trends have been described...
    0 Commentaires 0 parts
    Please log in to like, share and comment!
  • SUHAS KANDE added new article
    2025-08-29 12:35:59 -
    Kidney Transplant Immunosuppressant Drugs Market Overview, Growth Analysis, Trends and Forecast By 2032
    "Executive Summary Kidney Transplant Immunosuppressant Drugs Market Size and Share: Global Industry Snapshot The global kidney transplant immunosuppressant drugs market size was valued at USD 2.09 billion in 2024 and is projected to reach USD 4.55 billion by 2032, with a CAGR of 10.30% during the forecast period of 2025 to 2032. Businesses can depend with confidence upon this superior...
    0 Commentaires 0 parts
    Please log in to like, share and comment!
  • SUHAS KANDE added new article
    2025-09-03 12:09:15 -
    Middle East and Africa Calcineurin Inhibitors Market Overview, Growth Analysis, Trends and Forecast By 2032
    "Executive Summary Middle East and Africa Calcineurin Inhibitors Market Size and Share Analysis Report Middle East and Africa calcineurin inhibitors market size was valued at USD 320.58 million in 2024 and is projected to reach USD 642.19 million by 2032, with a CAGR of 9.1% during the forecast period of 2025 to 2032. Businesses are very much depending on the diverse segments involved in...
    0 Commentaires 0 parts
    Please log in to like, share and comment!
  • SUHAS KANDE added new article
    2025-09-03 12:28:09 -
    North America Calcineurin Inhibitors Market Overview, Growth Analysis, Trends and Forecast By 2032
    "Global Executive Summary North America Calcineurin Inhibitors Market: Size, Share, and Forecast North America calcineurin inhibitors market size was valued at USD 3.12 billion in 2024 and is projected to reach USD 7.14 billion by 2032, with a CAGR of 10.9% during the forecast period of 2025 to 2032.  To gain meaningful market insights and thrive in this competitive market place, North...
    0 Commentaires 0 parts
    Please log in to like, share and comment!
  • Kan Kumar added new article
    2025-06-20 07:23:11 -
    Psoriasis Vulgaris Drugs Market to 2032: Clinical Studies, Regulatory Approvals (EMA, PDMA, FDA), Drug Market, Incidence, Pharmacotherapy, Data Analysis, Treatment Options, Industry Players - DelveInsight Report
    Key participants in the psoriasis vulgaris industry include Meiji Seika Pharma, Dermavant Sciences, Bristol-Myers Squibb, Bio-Thera Solutions, Amgen, Arcutis Biotherapeutics, and UCB Pharma, in addition to other organizations operating in the psoriasis vulgaris market. Psoriasis Vulgaris Drug Market Analysis (Albany, USA) DelveInsight's comprehensive psoriasis vulgaris market analysis report...
    0 Commentaires 0 parts
    Please log in to like, share and comment!
  • Kan Kumar added new article
    2025-06-20 08:18:37 -
    Psoriasis Vulgaris Drugs Market to 2032: Clinical Studies, Regulatory Approvals (EMA, PDMA, FDA), Drug Market, Incidence, Pharmacotherapy, Data Analysis, Treatment Options, Industry Players - DelveInsight Report
    Key participants in the psoriasis vulgaris industry include Meiji Seika Pharma, Dermavant Sciences, Bristol-Myers Squibb, Bio-Thera Solutions, Amgen, Arcutis Biotherapeutics, and UCB Pharma, in addition to other organizations operating in the psoriasis vulgaris market. Psoriasis Vulgaris Drug Market Analysis (Albany, USA) DelveInsight's comprehensive psoriasis vulgaris market analysis report...
    0 Commentaires 0 parts
    Please log in to like, share and comment!
© 2025 The Social Network THESN French
English French Dutch
About Conditions Confidentialité Contact Us Annuaire